Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices

United Kingdom Nephrology and Urology Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   101
ISBN Number   not applicable
Product Code   GMD1151
Ask a question about this product?

Price £975.00

approximately: $1,496 | €1,147

Summary


United Kingdom Nephrology and Urology Investment Opportunities Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to United Kingdom nephrology & urology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the nephrology & urology devices in United Kingdom.

Scope

  • The report provides nephrology and urology devices information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the nephrology and urology devices market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Nephrology and Urology Devices
    • 3.2 Incontinence Devices
      • 3.2.1 Protective garments for incontinence
      • 3.2.2 Urine Bags
      • 3.2.3 Urinary Catheters
    • 3.3 Renal Dialysis Equipment
      • 3.3.1 Hemodialysis Machines
      • 3.3.2 Peritoneal Dialysis Solutions
      • 3.3.3 Continuous Renal Replacement Therapy Machines
      • 3.3.4 Dialysis Accessories
        • 3.3.4.1 AV Fistula Needles
        • 3.3.4.2 Blood Tubing Sets
        • 3.3.4.3 Dialysis Catheters
        • 3.3.4.4 Dialyzers
    • 3.4 Lithotripters
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
    • 4.4 United Kingdom Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of Medical Devices
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
        • 5.1.2.4 Class III devices
    • 5.2 Medical Device approval fee
    • 5.3 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Government Policies for Reimbursement
  • 7 Distribution Structure
  • 8 United Kingdom Medical Equipment Cross Market Comparison
  • 9 Nephrology and Urology Devices In United Kingdom
    • 9.1 Nephrology and Urology Devices Cross Country Comparison (2000-2012)
    • 9.2 Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • 9.3 Nephrology and Urology Devices, United Kingdom, Category Volume (Units), 2000-2012
    • 9.4 Nephrology and Urology Devices, United Kingdom, Company Share (2006-2007)
  • 10 Incontinence Devices In United Kingdom
    • 10.1 Incontinence Devices Overall Revenue (2000-2012)
    • 10.2 Incontinence Devices Overall Volume (2000-2012)
    • 10.3 Incontinence Devices Average Price (2000-2012)
    • 10.4 Incontinence Devices Distribution Share (2006-2007)
    • 10.5 Incontinence Devices, United Kingdom, Company Share (2006-2007)
  • 11 Lithotripters In United Kingdom
    • 11.1 Lithotripters Overall Revenue (2000-2012)
    • 11.2 Lithotripters Overall Volume (2000-2012)
    • 11.3 Lithotripters Average Price (2000-2012)
    • 11.4 Lithotripters Distribution Share (2006-2007)
    • 11.5 Lithotripters, United Kingdom, Company Share (2006-2007)
  • 12 Renal Dialysis Equipment In United Kingdom
    • 12.1 Renal Dialysis Equipment Overall Revenue (2000-2012)
    • 12.2 Renal Dialysis Equipment Overall Volume (2000-2012)
    • 12.3 Renal Dialysis Equipment Average Price (2000-2012)
    • 12.4 Renal Dialysis Equipment Distribution Share (2006-2007)
    • 12.5 Renal Dialysis Equipment, United Kingdom, Company Share (2006-2007)
  • 13 Svenska Celullosa Aktiebolaget SCA Company Profile
    • 13.1 Company Overview
  • 14 Fresenius Medical Care AG & Co. KGaA Company Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
        • 14.2.1.1 In House Manufacturing
      • 14.2.2 Product Development
        • 14.2.2.1 Regulatory Approvals
        • 14.2.2.2 Research and Development
      • 14.2.3 Sales and Marketing
        • 14.2.3.1 Partnerships and Alliances
        • 14.2.3.2 Licensing Agreements
  • 15 Gambro AB Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
        • 15.2.1.1 In House Manufacturing
      • 15.2.2 Product Development
        • 15.2.2.1 Regulatory Approvals
        • 15.2.2.2 Clinical Trials
        • 15.2.2.3 Research and Development
      • 15.2.3 Sales and Marketing
        • 15.2.3.1 Partnerships and Alliances
        • 15.2.3.2 Licensing Agreements
  • 16 HARTMANN GROUP Company Profile
    • 16.1 Company Overview
    • 16.2 Value Chain Analysis
      • 16.2.1 Manufacturing
        • 16.2.1.1 Outsourcing
        • 16.2.1.2 In House Manufacturing
      • 16.2.2 Product Development
        • 16.2.2.1 Regulatory Approvals
        • 16.2.2.2 Research and Development
      • 16.2.3 Sales and Marketing
        • 16.2.3.1 Partnerships and Alliances
  • 17 ONTEX International N.V. Company Profile
    • 17.1 Company Overview
  • 18 Coloplast A/S Company Profile
    • 18.1 Company Overview
    • 18.2 Value Chain Analysis
      • 18.2.1 Manufacturing
        • 18.2.1.1 In House Manufacturing
      • 18.2.2 Product Development
        • 18.2.2.1 Regulatory Approvals
        • 18.2.2.2 Clinical Trials
        • 18.2.2.3 Research and Development
      • 18.2.3 Sales and Marketing
        • 18.2.3.1 Partnerships and Alliances
        • 18.2.3.2 Licensing Agreements
  • 19 Beaucare Medical Ltd Company Profile
    • 19.1 Company Overview
  • 20 DEKA Research & Development Corporation Company Profile
    • 20.1 Company Overview
  • 21 Dorset Nursing Supplies Ltd. Company Profile
    • 21.1 Company Overview
  • 22 Femcare-Nikomed Limited Company Profile
    • 22.1 Company Overview
  • 23 Gaeltec Ltd. Company Profile
    • 23.1 Company Overview
  • 24 Gyne Ideas Ltd. Company Profile
    • 24.1 Company Overview
  • 25 Pennine Healthcare Limited Company Profile
    • 25.1 Company Overview
  • 26 S G & P Payne Company Profile
    • 26.1 Company Overview
  • 27 S Murray & Co Ltd Company Profile
    • 27.1 Company Overview
  • 28 Sigmacon (UK) Ltd Company Profile
    • 28.1 Company Overview
  • 29 Financial Deals Landscape
    • 29.1 Acquisition
      • 29.1.1 Olympus Acquires Gyrus Group
      • 29.1.2 B Braun Acquires Avitum
      • 29.1.3 Lidco Group Enters Into Agreement With Med-Dynamix
      • 29.1.4 Tissue Science Laboratories Enters Into Agreement With C.R. Bard
  • 30 Appendix
    • 30.1 Global Markets Direct Research Methodology
    • 30.2 Coverage
    • 30.3 Secondary Research
    • 30.4 Primary Research
    • 30.5 Models
    • 30.6 Forecasts
    • 30.7 Expert Panels
    • 30.8 Currency Conversion
    • 30.9 Contact Us
    • 30.10 Disclaimer
  • LIST OF TABLES
  • 1 List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: United Kingdom Healthcare Trade Statistics, 2001-2006
    • Table 3: Medical Device Approval Fee in UK, 2006
    • Table 4: United Kingdom, Medical Equipment Market Comparison
    • Table 5: Nephrology and Urology Devices Cross Country Comparison (2000-2012)
    • Table 6: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Table 7: Nephrology and Urology Devices Market, United Kingdom, Portfolio Analysis
    • Table 8: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 9: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 10: Nephrology and Urology Devices, United Kingdom, Category Volume (Units), 2000-2012
    • Table 11: Nephrology and Urology Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Table 12: Nephrology and Urology Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Table 13: Nephrology and Urology Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 14: Incontinence Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 15: Incontinence Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 16: Incontinence Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 17: Incontinence Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 18: Incontinence Devices, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 19: Incontinence Devices, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 20: Incontinence Devices, United Kingdom, Distribution Share by Revenue, 2006-2007
    • Table 21: Incontinence Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 22: Lithotripters, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 23: Lithotripters, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 24: Lithotripters, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 25: Lithotripters, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 26: Lithotripters, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 27: Lithotripters, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 28: Lithotripters, United Kingdom, Distribution Share by Revenue, 2006-2007
    • Table 29: Lithotripters, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 30: Renal Dialysis Equipment, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 31: Renal Dialysis Equipment, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 32: Dialysis Accessories, United Kingdom, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 33: Dialysis Accessories, United Kingdom, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Table 34: Renal Dialysis Equipment, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 35: Renal Dialysis Equipment, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 36: Dialysis Accessories, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2007
    • Table 37: Dialysis Accessories, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2007-2012
    • Table 38: Renal Dialysis Equipment, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 39: Renal Dialysis Equipment, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 40: Renal Dialysis Equipment, United Kingdom, Distribution Share by Revenue, 2006-2007
    • Table 41: Renal Dialysis Equipment, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 42: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 14: United Kingdom, Medical Equipment Market Comparison,2007
    • Figure 15: Nephrology and Urology Devices Cross Country Comparison (2000-2012)
    • Figure 16: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Figure 17: Nephrology and Urology Devices Market, United Kingdom, Portfolio Analysis
    • Figure 18: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 19: Nephrology and Urology Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 20: Nephrology and Urology Devices, United Kingdom, Company Share (%), 2007
    • Figure 21: Incontinence Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 22: Incontinence Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 23: Incontinence Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 24: Incontinence Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 25: Incontinence Devices, United Kingdom, Company Share (%), 2007
    • Figure 26: Lithotripters, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 27: Lithotripters, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 28: Lithotripters, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 29: Lithotripters, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 30: Lithotripters, United Kingdom, Company Share (%), 2007
    • Figure 31: Renal Dialysis Equipment, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 32: Renal Dialysis Equipment, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 33: Dialysis Accessories, United Kingdom, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 34: Dialysis Accessories, United Kingdom, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012
    • Figure 35: Dialysis Accessories, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2007
    • Figure 36: Dialysis Accessories, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2007-2012
    • Figure 37: Renal Dialysis Equipment, United Kingdom, Company Share (%), 2007
    • Figure 38: Fresenius Medical Care AG & Co. KGaA Value Chain Analysis
    • Figure 39: Gambro AB Value Chain Analysis
    • Figure 40: Hartmann Group Value Chain Analysis
    • Figure 41: Coloplast A/S Value Chain Analysis
    • Figure 42: Global Markets Direct Methodology